Provided by Tiger Trade Technology Pte. Ltd.

Hyphens Pharma

0.365
0.000
Volume:75.30K
Turnover:27.49K
Market Cap:112.79M
PE:19.21
High:0.370
Open:0.365
Low:0.365
Close:0.365
52wk High:0.385
52wk Low:0.287
Shares:309.00M
Float Shares:65.94M
Volume Ratio:0.15
T/O Rate:0.11%
Dividend:0.02
Dividend Rate:4.11%
EPS(TTM):0.019
EPS(LYR):0.019
ROE:12.97%
ROA:7.20%
PB:1.70
PE(LYR):19.62

Loading ...

Hyphens Pharma International Limited reports 132.5% rise in first-half net profit on higher margins

SGX Filings
·
Aug 17

Singapore's Medtecs HY Profit Jumps on Higher Revenue, Lower Taxes

Reuters
·
Aug 14

Singapore's AsiaMedic HY Loss Narrows Sharply on Diagnostic Imaging Growth

Reuters
·
Aug 14

Hyphens Pharma 1H2026 revenue at S$89.1 million, profit at S$4.6 million on margin-focused portfolio mix

SGX Filings
·
Aug 13

Singapore's Hyphens Pharma Half-Year Profit Jumps as Margins Improve

Reuters
·
Aug 13

Hyphens Pharma International Ltd H1 Revenue SGD 89.1 Million

THOMSON REUTERS
·
Aug 13

Hyphens Pharma International Ltd H1 Pretax Profit SGD 6.3 Million

THOMSON REUTERS
·
Aug 13

Hyphens Pharma International Ltd H1 Net Income SGD 4.6 Million

THOMSON REUTERS
·
Aug 13

kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist

sgx.com
·
Jun 17

Directors Increase Stakes, Including Aspial Lifestyle, Raffles Medical and Centurion

SGX
·
May 25

Hyphens Pharma International approves FY2025 dividend and other key resolutions at Apr, 28 2026 AGM

SGX Filings
·
May 22

Hyphens Pharma International completes final 18% buyout of Ardence Pharma

SGX Filings
·
Apr 29

Hyphens Pharma answers shareholder questions ahead of Apr 28 AGM

SGX Filings
·
Apr 21

Hyphens Pharma announces annual general meeting

Reuters
·
Apr 21

Hyphens Pharma International Ltd. reports Non-Executive Director Dr Tan Kia King acquisition of securities

Reuters
·
Mar 02

Hyphens Pharma International books lower FY2025 revenue but lifts gross margin to record 40.7%

SGX Filings
·
Feb 27

Hyphens Pharma FY2025 revenue at S$177.4 million, profit at S$6.1 million on portfolio shift to higher-margin products

SGX Filings
·
Feb 24

Hyphens Pharma FY2025 profit after tax falls 43.6% to SGD 6.1 million

Reuters
·
Feb 24

Hyphens Pharma International Ltd FY Revenue SGD 177.4 Million

THOMSON REUTERS
·
Feb 24

Hyphens Pharma International - Proposes a Final Dividend of 1.5 Singapore Cents for FY2025

THOMSON REUTERS
·
Feb 24